ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab? chelfand Sun, 05/31/2020 – 16:58
Category: Uncategorized
Pfizer’s Ibrance misses shot at big new market with early breast cancer failure chelfand Sat, 05/30/2020 – 17:46
Updated Date: Fri, 22 May 2020 00:00:00 EDT
Updated Date: Fri, 22 May 2020 00:00:00 EDT
Updated Date: Fri, 22 May 2020 00:00:00 EDT
Updated Date: Fri, 22 May 2020 00:00:00 EDT
Updated Date: Fri, 22 May 2020 00:00:00 EDT
AbbVie scores ‘game-changer’ nod for Oriahnn in uterine fibroids chelfand Fri, 05/29/2020 – 14:57
Roche’s Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod chelfand Fri, 05/29/2020 – […]
